Quinizarin

CAS No. 81-64-1

Quinizarin( 1,4-Dihydroxyanthraquinone )

Catalog No. M24808 CAS No. 81-64-1

Quinizarin is a natural product.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 44 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 39 In Stock

Biological Information

  • Product Name
    Quinizarin
  • Note
    Research use only, not for human use.
  • Brief Description
    Quinizarin is a natural product.
  • Description
    Quinizarin is a natural product.
  • In Vitro
    1,4-Dihydroxyanthraquinone (1,4-DHAQ, a fluorophore) doped cellulose (CL) (denoted as 1,4-DHAQ@CL) microporous nanofiber film has been achieved via simple electrospinning and subsequent deacetylating, and used for highly sensitive and selective fluorescence detection of Cu(2+) in aqueous solution.
  • In Vivo
    ——
  • Synonyms
    1,4-Dihydroxyanthraquinone
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    81-64-1
  • Formula Weight
    240.21
  • Molecular Formula
    C14H8O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 3.33 mg/mL (13.86 mM)
  • SMILES
    Oc(c(C(c1c2cccc1)=O)c1C2=O)ccc1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Rosuvastatin lactone

    Rosuvastatin lactone is the lactone form of the HMG-CoA reductase inhibitor rosuvastatin. It is found in vivo following rosuvastatin administration.

  • Nonapeptide-1

    Nonapeptide-1 can inhibit the synthesis of melanin which makes it of interest for treating certain skin conditions.?

  • Ganoderenic acid B

    Ganoderenic acid B, a natural product derived from Ganoderma lucidum, can work by inhibiting the transport function of ABCB1 and enhancing the cytotoxicity of chemotherapy drugs against AbCB1-mediated multidrug resistant cancer cells.